Skin stem cells (SCs) are specified and rapidly expanded to fuel body growth during early development. However, the molecular mechanisms that govern the amplification of skin SCs remain unclear. Here we report an essential role for miR-205, one of the most highly expressed microRNAs in skin SCs, in promoting neonatal expansion of these cells. Unlike most mammalian miRNAs, genetic deletion of miR-205 causes neonatal lethality with severely compromised epidermal and hair follicle growth. In the miR-205 knockout skin SCs, phospho-Akt is significantly downregulated, and the SCs prematurely exit the cell cycle. In the hair follicle, this accelerates the transition of the neonatal SCs towards quiescence. We identify multiple miR-205-targeted negative regulators of PI(3)K signalling that mediate the repression of phospho-Akt and restrict the proliferation of SCs. Our findings reveal an essential role for miR-205 in maintaining the expansion of skin SCs by antagonizing negative regulators of PI(3)K signalling.
Skin stem cells (SCs) are specified and rapidly expanded to fuel body growth during early development. However, the molecular mechanisms that govern the amplification of skin SCs remain unclear. Here we report an essential role for miR-205, one of the most highly expressed microRNAs in skin SCs, in promoting neonatal expansion of these cells. Unlike most mammalian miRNAs, genetic deletion of miR-205 causes neonatal lethality with severely compromised epidermal and hair follicle growth. In the miR-205 knockout skin SCs, phospho-Akt is significantly downregulated, and the SCs prematurely exit the cell cycle. In the hair follicle, this accelerates the transition of the neonatal SCs towards quiescence. We identify multiple miR-205-targeted negative regulators of PI(3)K signalling that mediate the repression of phospho-Akt and restrict the proliferation of SCs. Our findings reveal an essential role for miR-205 in maintaining the expansion of skin SCs by antagonizing negative regulators of PI(3)K signalling.
Tissue SCs are specified during early development. In mouse skin, hair follicle (HF) SCs (HFSCs) emerge between embryonic day 14 (E14) and postnatal day 0.5 (P0.5) at the initiation of HF morphogenesis 1 . These newly specified SCs must undergo proliferative expansion to accommodate body growth and enlargement of individual tissues. In adults, however, HFSCs form a quiescent cell population that infrequently cycle and maintain the SC pool throughout life 2, 3 . Therefore, there is a transition leading proliferative SCs to exit the cell cycle and become quiescent. During this transition, gene regulatory networks balancing output from multiple pathways regulating proliferation, quiescence, survival and cell death must be precisely coordinated 4, 5 . In skin, the molecular mechanisms governing the transition of SCs from the expansion phase to quiescence remain poorly understood.
MicroRNAs (miRNAs), a class of tiny regulatory RNAs, have been proposed to play important roles in diverse biological processes 6 . However, few studies have specifically addressed the role played by individual miRNAs in the expansion and maintenance of tissue SCs during mammalian development in vivo 7 . Although global ablation of the miRNA pathway through genetic deletion of either Dicer or Dgcr8 has provided insights into the requirement of miRNAs in embryonic SCs and tissue development [8] [9] [10] [11] [12] [13] , the pleiotropic defects caused by the loss of hundreds of miRNAs make it impossible to elucidate the underlying mechanisms. Surprisingly, it has not yet been reported that the loss of a single miRNA leads to severe defects either in animal development or in tissue SCs, in contrast to lethal phenotypes often observed in Dicer or Dgcr8 conditional knockout (cKO) animals 7, 14, 15 . Thus, it remains a major challenge to characterize the functional significance of individual miRNAs in tissue SCs and elucidate their molecular mechanisms.
Here we report that miR-205 is one of the most highly expressed miRNAs in skin SCs. We demonstrate by genetic deletion of miR-205 that miR-205 is not only essential for mouse development but also specifically required for the expansion of the progenitor and SC populations in both epidermis and HFs during neonatal skin development. Furthermore, we provide mechanistic insights into miR-205 function by demonstrating potent regulation of the PI(3)K pathway. Together, this study establishes a paradigm for the role of individual miRNAs in balancing the proliferation and quiescence of tissue SCs during early development.
RESULTS

miR-205 is highly enriched in skin progenitors and SCs
We have previously shown that both Dicer and Dgcr8 skin cKO animals exhibit a much smaller body size and shortened HFs ( Supplementary  Fig. S1a) 10, 13 . When we monitored the dynamics of the HFSCs, we observed that HFSC specification was intact in the absence of Dicer in the newborn skin, as determined by immunofluorescence staining of Nfatc1 (refs 1,16 and Supplementary Fig. S1b ). However, in P4.5 Dicer cKO skin, the Nfatc1+ HFSC population was absent ( Supplementary  Fig. S1c ) and the Sox9+ HFSCs and progenitor cells 1, 17 were also significantly reduced in the bulge ( Supplementary Fig. S1d ). These observations indicate that global miRNA expression is required for the expansion and self-renewal of HFSCs during neonatal development. We then performed in situ hybridization to determine the expression patterns for the 10 most highly expressed miRNAs in neonatal skin 13 . We found that miR-205 is highly enriched in skin progenitors and SCs during skin development ( Fig. 1a-e ). At E10, when the skin still comprises a single layer of multipotent embryonic skin progenitors, miR-205 was already detectable in the cytoplasm of these p63+ progenitors 18 (Fig. 1a ). At E14, when the basal cells begin to stratify, miR-205 was restricted to the basal progenitors, and was absent from the differentiating suprabasal cells (Fig. 1b ). When the HF lineage begins to emerge from the basal layer, miR-205 was further upregulated in the HF placode ( Fig. 1c ). When visualized in both neonatal and adult skin, miR-205 was expressed in interfollicular progenitor cells but most highly enriched in the bulge, where HFSCs reside (Fig. 1d ,e and Supplementary Fig. S2a ).
To quantify the differential expression of miR-205 in the epidermal and HF lineages, we isolated interfollicular progenitors, HFSCs, outer root sheath (ORS) progenitors and transient-amplifying matrix (Mx) cells with a K14-RFP/Sox9-GFP mouse model 19 in P4 skin ( Supplementary Fig. S2c ). We validated each population by quantitative real-time PCR with reverse-transcription (qRT-PCR) for well-established marker genes ( Fig. 1f ). We then determined that miR-205 was expressed at the highest level in the HFSCs, followed by the interfollicular progenitors and the ORS, when compared with the Mx cells ( Fig. 1g ). When we quantified miR-205 in telogen (P19) and anagen (P28) bulge as α6 hi CD34 hi populations 20 , we observed higher expression in the telogen HFSCs ( Supplementary Fig. S2b ). Together, our in situ and qRT-PCR analyses identify miR-205 as one of the most highly expressed miRNAs in skin progenitors and SCs.
We next determined the level of miR-205 expression among different murine tissues. In a comprehensive survey of miRNA expression patterns in mouse and human, miR-205 was detected only in epithelial tissues that include skin, prostate and mammary gland 21 . Similarly, when we quantified miR-205 expression in 12 murine tissues obtained from P7.5 animals with qRT-PCR, we found that miR-205 was strongly enriched in stratified epithelial tissues including skin, tongue, bladder and stomach and largely absent from other tissues ( Fig. 1h ). Furthermore, in situ hybridization for miR-205 together with a well-established basal epithelial cell marker, Krt5 (K5), revealed that miR-205 was expressed only in K5+ cells in all tissues examined ( Supplementary Fig. S3a-b ). Although it remains a possibility that miR-205 may be expressed in rare cell populations in non-epithelial tissues, these data suggest that miR-205 is highly specific for K5+ basal cells within stratified epithelial tissues.
Generation of miR-205 KO mouse
The miR-205 gene is located in an intergenic region on mouse chromosome 1. The primary transcript of miR-205 has been previously detected in mouse neonatal skin complementary DNA as a non-coding RNA (AK014513, UCSC genome browser; Fig. 2a and Supplementary  Fig. S4a ). By using chromatin immunoprecipitation sequencing (ChIP-seq) for H3K4me3 and H3K36me3 marks that define actively transcribed genomic regions by RNA polymerase II (ref. 22) , we determined that the primary transcript of miR-205 was transcribed in E14 basal cells ( Fig. 2a ). With RNA sequencing (RNA-seq) specifically for the polyA tail 23 , we determined that the primary transcript was polyadenylated using a canonical signal (AUUAAA; Fig. 2a ). Although mature miR-205 sequences are highly conserved in vertebrates, the primary transcript shows poor conservation outside the miR-205 hairpin ( Supplementary Fig. S4 ). We then generated a miR-205 KO mouse model ( Fig. 2b-d ) and validated the complete ablation of miR-205 by qRT-PCR and in situ ( Fig. 2e ).
miR-205 KO mouse is neonatal lethal
miR-205 KO animals were born with the expected Mendelian ratio (wild type (WT)/het/KO = 137(22%):328(53%):156(25%)). Whereas the KO animals were indistinguishable in appearance from their WT or heterozygous littermates at birth, by P5 they became weaker and had less well-developed hair coats ( Fig. 3a ). miR-205 KO animals usually died ∼10 days after birth, whereas the heterozygous animals showed no sign of any defects and were indistinguishable from their WT littermates. Therefore, the loss of miR-205 has dire consequences leading to neonatal lethality, unlike many individual miRNA KOs that are apparently normal and lack obvious developmental defects 14 . We investigated miR-205 in the skin because of the clear similarities in the miR-205 KO and the Dicer skin cKO animals, and because of the high miR-205 levels in skin. At P4.5, the miR-205 KO skin developed thinner epidermis (Fig. 3b ). The HFs were short and also mis-angled, similar to the HFs that grow downward in the Dicer cKO ( Fig. 3c ). The terminal differentiation of both epidermal and HF lineages in the miR-205 KO was not markedly altered, as judged by immunofluorescence staining of skin lineage markers ( Supplementary Fig. S5 ). Furthermore, these animals did not exhibit any discernible barrier defects ( Fig. 3d ). We did not observe any evaginating HFs and apoptotic cells, hallmarks of the Dicer cKO skin 9,10 , suggesting that the absence of other miRNAs may be responsible for these defects.
Ablation of miR-205 impairs the proliferation of interfollicular progenitors
To examine the interfollicular progenitors 24 , we bred miR-205 +/− to K14-RFP mice so that we could identify the progenitors by α6 hi /RFP hi expression in the epidermal fraction after separating the epidermis from HFs ( Supplementary Fig. S2c ). The miR-205 KO progenitors exhibited significantly reduced proliferation when compared with their WT counterparts using BrdU cell-cycle analysis. Whereas an average of 35.7% of the progenitors were BrdU+ in the WT, only 12.6% were BrdU+ in the miR-205 KO (Fig. 4a ). Therefore, the compromised proliferation probably contributes to the thinner epidermis, as well as the smaller skin surface of miR-205 KO animals ( Fig. 4b ). To further document the proliferation defects in vivo, we used Ki67 staining to distinguish cells that were in active cell cycle from those that exited the cell cycle. At P4.5, 88.9% of interfollicular progenitors were positive for Ki67 in the WT skin. In contrast, only 52.3% of progenitors were positive for Ki67 in the miR-205 KO skin. By P7.5, 55.1% of interfollicular progenitors were positive for Ki67 in the WT, whereas the Ki67+ population dropped to 24.9% in the miR-205 KO skin ( Fig. 4c ). To distinguish whether these defects were intrinsic to the loss of miR-205 in the skin or due to systemic effects, we grafted WT and KO skin onto nude mice ( Supplementary Fig. S6 ). In agreement with the cell-autonomous role of miR-205, the transplanted KO skin showed much fewer Ki67+ cells than the WT skin ( Fig. 4d,e ). We next isolated the interfollicular progenitors from both WT and KO skin and compared their colony formation capacity in vitro. We observed a strong reduction in the formation of large, holoclonal colonies by miR-205 KO progenitors even though the total number of colonies was similar ( Fig. 4f ). Collectively, these data suggest that the loss of miR-205 directly compromises the proliferation and leads to premature cell-cycle exit in the interfollicular progenitors.
Ablation of miR-205 compromises the proliferation of progenitors and SCs cells in HFs
In the HF lineage, BrdU analysis revealed that the HFSCs and ORS progenitor cells were also less proliferative in the KO skin ( Fig. 5a,b) .
In contrast, the transient-amplifying Mx cells were equally proliferative between the WT and KO samples ( Fig. 5c ). As miR-205 is highly enriched in the HFSCs and ORS but not in the Mx cells, these data indicate that the loss of miR-205 specifically compromises the proliferation of the progenitors and HFSCs. Consistent with the impaired cell-cycle progression, when we quantified the HFSC population by immunofluorescence staining for Nfatc1 or Sox9, miR-205 KO showed a mild but statistically significant reduction in the number of HFSCs (Fig. 5d,e ). This indicates that the compromised proliferation leads to a smaller HFSC population in the absence of miR-205. The diminished SC and ORS progenitor population probably reduced the supply for transient-amplifying Mx cells, leading to smaller hair bulbs, even though all Mx cells were still actively cycling in the KO (Fig. 5f ). Unlike interfollicular progenitors, HFSCs in adult skin are quiescent and become activated to fuel hair cycle only periodically or in response to epidermal wound repair 3, 24, 25 . However, HFSCs are specified during hair morphogenesis 1 and they must undergo neonatal expansion before entering quiescence. As the deletion of miR-205 causes impaired HFSC proliferation, we investigated whether miR-205 plays a key role in the transition from proliferation to quiescence. We first monitored the dynamics of newly specified HFSCs as marked by Nfatc1 during embryonic skin development 1, 16, 17 . At E17.5, all of these nascent HFSCs were actively cycling as indicated by strong Ki67 signals in the newly formed hair germ ( Supplementary Fig. S7a ). At P0.5, all of these HFSCs were still Ki67+, reflecting a continuous expansion of the HFSC population to fuel HF growth ( Supplementary Fig. S7b ). By P1.5, however, a few Nfatc1+ HFSCs especially those in mature HFs began to lose Ki67 signals, marking the onset of the transition towards quiescence (Supplementary Fig. S7c ). By P4.5, 47.5% of the WT HFSCs lost Ki67 signal and 28.2 ± 4.9 12.5 ± 2.8 19.9 ± 0.4 8.9 ± 0.7 6.1 ± 0. transitioned towards quiescence. In contrast, 68.4% of the miR-205 KO HFSCs lost Ki67 signal and became quiescent (Fig. 5g ). Furthermore, reduced HFSC proliferation led to the accumulation of label-retaining cells in the KO bulge in a BrdU pulse-chase experiment (Fig. 5h ). Together, these analyses suggest the possibility that miR-205 KO HFSCs prematurely exit the cell cycle and transition towards quiescence. Supplementary Fig. S9 .
Although miR-205 is most highly expressed in HFSCs, it is also expressed in the ORS. As expected, we observed a marked decrease in Ki67+ cells in the miR-205 KO ORS (Fig. 5i ). The ORS cells constitute the main portion of the HF in length, such that their reduced proliferation probably contributed to the shortened HFs as seen in the KO skin. Taken together, these in vivo results provide insights into the requirement for miR-205 to maintain cell proliferation in neonatal HFSCs and progenitors.
We next isolated HFSCs from WT and miR-205 KO skin and compared their colony formation capacity in vitro. We first confirmed that both WT and KO cells had similar plating efficiencies (Fig. 5j) . Importantly, miR-205 KO HFSCs showed significantly compromised colony formation capacity such that the number of large holoclones was markedly reduced (Fig. 5k ). Together, these findings demonstrate that miR-205 is intrinsically required for the proliferation of HFSCs both in vivo and in vitro.
Ablation of miR-205 impairs the proliferation of basal cells in stratified epithelium
As miR-205 was detected in K5+ basal cells in other stratified epithelium located in oesophagus and tongue ( Supplementary Fig. S3a) , we examined the cell proliferation in these tissues. As expected, the proliferation of K5+ basal cells in oesophagus and tongues was also compromised, as judged by both Ki67 and BrdU labelling (Fig. 6) . These results indicate a general requirement for miR-205 in K5+ basal cells of the stratified epithelium. Furthermore, compromised proliferation in multiple stratified epithelial tissues could contribute to the lethality of miR-205 KO animals.
miR-205 directly targets multiple negative regulators of the PI(3)K pathway
To identify direct targets of miR-205, we isolated the HFSCs from WT and miR-205 KO skin at P4 and compared messenger RNA expression by microarray analysis. We identified 201 genes that were consistently upregulated more than 20% in miR-205 KO samples in two sets of biological duplicates. We performed a motif search for all possible heptanucleotides that are represented in the miR-205 sequences in the 5 UTR, coding region and 3 UTR of these genes. We found that only the 1-7, 2-8 and 3-9 seed motifs, which are located at the 5 end of miR-205, were significantly enriched only in the 3 UTRs of the upregulated genes ( Fig. 7a and Supplementary Fig. S8a-c) . As a control, we did not observe any enrichment for any heptanucleotides motif represented by miR-1 ( Supplementary Fig. S8d) . These results indicate, as expected, that miR-205 selectively represses the expression of genes that bear its seed sequences in their 3 UTR. Out of 201 upregulated genes, 96 genes (47.8%) contain at least one miR-205 seed match in their 3 UTR ( Supplementary Table S1 ). Collectively, these results support the cell-autonomous role of miR-205 in modulating gene expression in the HFSCs.
We performed a pathway analysis for these 96 genes 26 and identified tumour suppressor as the most significantly enriched SwissProt/PIR keyword. Derepression of tumour suppressor genes (TSGs) is known to inhibit self-renewal and reduce SC populations [27] [28] [29] . In our list, APC, Frk, Inpp4b and Phlda3 are known TSGs (refs 30-32) . We also identified Inppl1, a known negative regulator in the PI(3)K pathway 33 , which is a previously identified miR-205 target in human keratinocytes 34, 35 . To validate these targets, we first determined the 3 UTR for each gene using our RNA-seq database generated from the HFSCs and then tested their responsiveness to miR-205 by insertion 3 to a luciferase indicator gene, with both WT and mutated miR-205 seed sequences ( Supplementary Fig. S8e) . Four of five genes were robustly regulated by miR-205 as demonstrated by derepressed luciferase activity when the miR-205 target site(s) was mutated (Fig. 7b ). Among these targets, Phlda3 and Inppl1 were abundantly expressed and we further validated their upregulation at the protein level by western blotting with fluorescence-activated cell sorting (FACS)-purified interfollicular progenitors and HFSCs (Fig. 7c ). When we used the purified Mx cells as a control, we did not detect Phlda3 in either WT or KO cells and we did not observe upregulation of Inppl1 in the KO Mx cells. These data confirm the specific regulation of these targets by miR-205 in interfollicular progenitors and HFSCs.
To provide more insights into the expression pattern of miR-205 and its target mRNAs, we isolated HFSCs and measured their expression level by qRT-PCR during embryonic/neonatal development. Interestingly, the expression of both miR-205 and these targets gradually increased from E17.5 to P3.5 and P10.5 (Fig. 7d ). This result suggests that miR-205 is upregulated to balance the enhanced expression of these TSGs.
miR-205 is required for the maintenance of pAkt levels
We noted that Frk, Inpp4b, Inppl1 and Phlda3 all negatively regulate the PI(3)K/Akt pathway [30] [31] [32] [33] . This prompted us to examine pAkt levels in the skin. Strikingly, the pAkt levels were significantly downregulated in interfollicular progenitors (90%), HFSCs (86%) and ORS (38%) but only slightly in the Mx cells (18%) in miR-205 KO skin (Fig. 8a) . To ensure that the downregulation of pAkt was specific to these skin lineages and not due to systemic defects in the miR-205 KO animals, we measured pAkt levels in other vital organs including brain, brown fat, heart and lung, and observed normal pAkt levels ( Supplementary  Fig. S8f ). Intriguingly, pAkt was also significantly downregulated in the Dicer cKO epidermis (95%; Fig. 8b) . These results suggest that miR-205 is specifically required to maintain pAkt levels in the progenitors and SCs in skin.
The level of pAkt has been directly linked to the proliferation and self-renewal of skin SCs (refs [36] [37] [38] . When we blocked pAkt using a small-molecule inhibitor of PI(3)K in cultured keratinocytes, the growth of primary keratinocytes was abolished ( Supplementary  Fig. S8g ). To determine whether the derepression of miR-205 targets, including Inpp4b, Frk, Phlda3 and Inppl1, dampens the PI(3)K/Akt pathway, we infected primary keratinocytes with MSCV vectors expressing each of these genes. On enhanced expression of these targets, pAkt levels were downregulated ( Fig. 8c ) and cell proliferation was compromised (Fig. 8d) . Interestingly, the ability to inhibit growth by these regulators correlated with their ability to reduce pAkt levels. This suggests that high pAkt levels are closely associated with proliferative capacity. Finally, to determine whether the downregulation of pAkt contributes primarily to the growth defects caused by the loss of miR-205, we infected the miR-205 KO HFSCs with a constitutively active Akt mutant (myr-Akt) and evaluated the colony formation capacity. As expected, myr-Akt largely rescued the growth defects of freshly isolated miR-205 KO HFSCs (Fig. 8e ). Taken together, these results argue that miR-205 co-represses multiple negative regulators of the PI(3)K/Akt pathway and, by doing so, miR-205 maintains a high pAkt level that promotes the proliferation and expansion of progenitors and SCs in developing skin (Fig. 8f ).
DISCUSSION
miRNAs have been implicated to have important roles in gene regulation in mammalian SCs (refs 7,39-41) . However, genetic KO models in either Caenorhabditis elegans or mouse have implicated very few individual miRNAs as indispensable for animal development 14, 15, 42 .
Here we report that miR-205 plays an essential role in promoting stem cell expansion during early development. This provides one of the first examples in which genetic deletion of a single miRNA causes severe developmental defects and compromises the function of tissue SCs.
Our study also provides further insights into the transition of neonatal HFSCs from the active cycling state to quiescence. We identify a network of negative regulators of the PI(3)K pathway that are directly targeted by miR-205. During skin development, the expression of these negative regulators and miR-205 increases concurrently. On the loss of miR-205, negative regulators of the PI(3)K pathway become prematurely elevated and reduce pAkt levels. Reduced pAkt levels then compromise the proliferation of the progenitor and SC populations in the skin. However, the proliferation defect alone probably does not cause the lethality. We note that miR-205 has been implicated to have important roles in the regulation of cell adhesion and migration 43, 44 . Positive regulators of cell migration, for example, Arhgap5 and Cxcl12, are also identified as targets of miR-205 ( Supplementary Table S1 ). It is an intriguing possibility that potential defects in cell migration could contribute to the severe developmental defects.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb2827 METHODS Mice. The miR-205 hairpin spans approximately 68 base pairs. A targeting vector was constructed, which carries a neomycin resistance (neo r ) gene flanked with two frt sites and a single lox-P site (neo r -frt2-loxP cassette) 3' of the miR-205 hairpin. A single loxP site (5'loxP) was placed 219 base pairs upstream of the miR-205 hairpin. The short arm of homology 3 of the neo r -frt2-loxP cassette is 3 kb, and the long arm of homology is 9.1 kb preceding the 5' loxP. The neo r -loxP and the 5' loxP are separated by 0.5 kb of DNA, which includes the miR-205 hairpin. The miR-205 targeting construct (pDTA-TK-miR-205) was transfected into E14.1 (B6) embryonic stem cells (ESCs). After the selection of transfected embryonic SCs with G418 and gancyclovir, individual colonies of ESC clones were collected and analysed for homologous recombination. Two targeted ESC clones were used to generate mice heterozygous for the miR-205-targeted allele. These mice were then crossed to the Flp-recombinase-expressing mouse strain (JAX, stock number: 003800) in the B6 background to remove the neo r -frt2 cassette and generate the miR-205 loxP allele. Mutant mice carrying floxed miR-205 alleles were crossed to transgenic mice (B6 background) expressing Cre recombinase under the control of the adenovirus EIIa promoter (JAX, stock number: 003724) to obtain miR-205 +/− mice. miR-205 +/+ and miR-205 +/− mice are referred to as WT, as they were indistinguishable by all assays performed here. In all of the experiments, the gender of the animals is not distinguished as both male and female KO show identical phenotypes.
The K14-RFP mouse was a gift from E. Fuchs (Rockefeller University, USA). The Sox9-GFP (Tg(Sox9-EGFP)EB209Gsat) mouse was obtained from MMRRC (stock number: 011019-UCD). Mouse colonies were maintained in the transgenic animal facility at the MCDB department of University of Colorado at Boulder. All animal experiments were conducted following protocols approved by the IACUC at University of Colorado.
Isolation and analysis of epidermal progenitor cells and hair follicle stem cells.
Postnatal day 4 (P4) K14-RFP/Sox9-GFP double transgenic mice were used for isolating hair follicle stem cells (HFSCs). HF/dermal and interfollicular progenitors were isolated as previously described 45 with minor modification. The full thickness skin was treated with dispase for 2 h at 37 • C to remove the epidermal sheets. Single cells were resuspended in PBS with 3% chelexed FBS and incubated with Alexa-Fluor-647-conjugated α6-integrin (1:75, AbD Serotec, catalogue number MCA699A647, clone NKI-GoH3) for 45 min on ice. Cell isolations were performed on Moflo XDP cell sorter (Beckman Coulter). Interfollicular progenitors in the basal epidermis were sorted according to their expression of K14-RFP and α6-integrin. HFSCs were gated as K14-RFP hi /Sox9GFP + /α6-integrin + , ORS were gated as K14-RFP hi /Sox9GFP − /α6-integrin + , and Matrix cells were gated as RFP low . For FACS purification and analysis of the miR-205 KO skin, miR-205 +/− mice were bred with K14-RFP/Sox9-GFP mice to generate miR-205 −/− /K14-RFP/Sox9-GFP and miR-205 +/+ /K14-RFP/Sox9-GFP littermates. These mice were backcrossed to B6 mice for at least three generations.
Flow cytometry for cell-cycle analysis. Five pairs of miR-205 −/− /K14-RFP/Sox9GFP and miR-205 +/+ /K14-RFP/Sox9-GFP postnatal day 4 (P4) pups were intraperitoneally injected with 50 µg g −1 body weight BrdU for 2 h before processing with HF/dermal and epidermal cell preparation. Isolated HF/dermal and epidermal cells were labelled with APC-BrdU Flow Kit (BD Biosciences). Cell-cycle profiles were acquired with CyAn analyser (Beckman Coulter) and then analysed with the FlowJo software.
Skin transplantation experiments.
Full-thickness grafts from newborn (postnatal day 0.5, P0.5) mice were performed as described previously 46 . In all cases, paired WT and miR-205 KO full-thickness back skin sections of similar size were grafted on a single female nu/nu (Nude) recipient. Five pairs of WT and miR-205 KO pups and five nude mice recipient were used in this experiment. Bandages were removed 14 days after grafting. One day after the removal, samples were taken for analysis.
HFSC label-retaining analysis.
For BrdU-label-retaining experiments, three pregnant females were injected at a dose of 50 µg per gram body weight BrdU for 3 doses from E17 to E18 every 12 h. Chase was for one week and skin samples were taken for analysis at P6.
ChIP-seq and RNA-seq. ChIP experiments were performed using the ChIP-IT Express kit from Active Motif (catalogue number 53008), following the manufacturer's suggested procedure. H3K4me3 antibody was purchased from Active Motif (catalogue number 39159) and H3K36me3 antibody was purchased from Abcam (catalogue number ab9050). For the 3Seq experiment, 0.5-2 µg total RNA was polyA selected twice using Invitrogen Dynabeads mRNA DIRECT Kit.
Then it was carried out as previously described 23 . For the ChIP-seq experiment, ChIP-ed DNA was purified and followed by the Illumina standard dsDNA library protocol described above.
RNA isolation and microarray analyses. Total RNAs from FACS-purified cells
were isolated using TRIZOL reagent (Invitrogen) and the quality was assessed by an Agilent 2100 bioanalyser. RNA (150 ng) was labelled using the Affymetrix 3 IVT express kit and then hybridized to GeneChip Mouse Genome 430 2.0 Arrays. Microarray image files were imported into the Bioconductor software. Background adjustment and normalization were carried out with the RMA method provided in Bioconductor. Probe sets that showed detectable signals and corresponded to known mRNA transcripts were considered for further analysis. Genes upregulated or downregulated more than 20% in both sets of biological experiments were considered to be differentially expressed.
Target analyses. The 5 UTR, CDS and 3 UTR of all genes annotated in the known gene table of the mouse genome database (mm9 version) were downloaded from the UCSC Genome Browser. The sequences obtained were used for enumeration of heptanucleotides and scanning of the miR-205 and miR-1 seeds. On the basis of the seed scanning results, genes upregulated more than 20% in miR-205 KO animals and containing at least one match in their 3 UTRs for seeds 1-7, 2-8, 3-9, 1-8 and 2-9 of miR-205 were considered to be putative miR-205 targets.
Clonogenic and myr-Akt rescue assays. For the basal epidermal progenitor cell colony formation assay, 3,000 FACS-sorted K14-RFP hi /α6-integrin + epidermal progenitor cells were plated onto mitomycin-C-treated 3T3 feeder cells in each well of a six-well plate. Two weeks after initial plating, colonies were counted and measured. The functional assay for miR-205 targets (Inpp4b, Frk, Phlda3 and Inppl1) was performed with cultured epidermal keratinocytes. Keratinocytes infected with MSCV empty vector or MSCV expressing these genes were sorted on the basis of GFP expression; 1,000 cells were plated in each well of a six-well plate. Two weeks after initial plating, colonies were counted and measured. For HFSCs, 30,000 FACS-sorted K14-RFP hi /Sox9GFP + /α6-integrin + HFSCs were plated in each well of a six-well plate in CnT-07 medium (Zen-bio). Ten days after initial plating, colonies were photographed and cells in each colony were counted. To test plating efficiency, 1,000 HFSCs were plated in each well of 12-well plates, and attached RFP+ cells were counted 24 h after plating.
For myr-Akt rescue assay, 30,000 FACS-sorted HFSCs were plated as above, and 48 h after plating, cells were infected with either MSCV empty vector or MSCV-myr-Akt. Eight days after infection, colonies were photographed and cells in each colony were counted.
Immunofluorescence, immunoblotting, antibodies and in situ hybridization.
Immunofluorescence and immunoblotting were performed as described previously 47 1,000 , R&D, catalogue number AF5389). In situ hybridizations were performed by adapting miRNA localization protocols to skin 47 . Signals were detected using the TSA Plus Fluorescein System (Perkin Elmer) for fluorescent signal and post-hybridization staining. The miRCURY LNA miR-205 detection probe (Exiqon) was 5'-DIG and 3'-DIG double labelled and hybridized to skin sections at 61 • C. Where shown, sections were stained with p63 or β4-integrin and Alexa-Fluor-594-conjugated secondary antibody (1:2,000, Invitrogen/Molecular Probes, catalogue number A11012 and A11007) after developing. For all of the immunoflourescence stainings, miR-205 in situ and immunoblots, at least 3 independent experiments were conducted. Representative images are shown in the figures.
Reverse transcription and real-time PCR miRNA expression analysis.
Reverse transcriptions were performed using miScript reverse transcription kit (Qiagen). Real-time PCR reagents and miScript primers for miRNAs and control Sno25 were from Qiagen. Reactions were performed according to the manufacturer's manual and on a CFX384 real-time system (Bio-Rad). Differences between samples and controls were calculated using the 2 − C(t) method.
DNA cloning, transfection and luciferase assay. 3 UTR fragments from candidate genes were amplified from cDNA prepared from FACS-purified ORS total RNA. The primers for APC were: 5 -GATCTCTAGAAGCTGGTGTTAATCACTACTGCTG-3 and 5 -GATCGATATCACCAAGCATTGAGAGGTGCT-3 ; the primers for Frk were: 5 -GATCTCTAGAACATCAAGGAAAAGAAGAAATAT-3 and 5 -GATCGATATCAACAGGGAAGTTCTTCAAGG-3 ; the primers for Inpp4b were: 5 -GATCACTAGTACCATCATGGAGACAAACAGGAAC-3 and 5 -GATCGATATCATGATGTGTCATGGCTTGGTTGCC-3 ; the primers for Inppl1 were: 5 -GATCTCTAGAGACACCTTGCAGCTCAGCAAATGA-3 and 5 -GATCGATATCTGAGTGCCCAAGGTGGGATAAACT-3 ; the primers for Phlda3 were: 5 -ATCGTCTAGAACCATGAGGCGTATCATTTTATCG-3 and 5 -ATCGCTCGAGTGGTTACTGCCCACGAACTGGG-3 . These fragments were validated by sequencing and inserted into multiple cloning sites in the 3 UTR of the pGL3-control plasmid (Promega). Mutations at target sites were obtained by recombinant PCR. Dual-luciferase assays were carried out as described previously 47 . The mouse cDNAs for Frk, Inpp4b, Phlda3 and Inppl1 were obtained from Open Biosystems, cloned into a MSCV-IRES-EGFP retroviral vector and validated by sequencing for in vitro function assay. Plasmids were transfected into Ampho cells to produce virus, and then infect keratinocytes. Forty-eight hours after infection, cells were sorted either for colony formation assay or for pAkt detection.
Image acquisition. For immunofluorescence stainings, imaging was performed on a Leica DM5500B microscope with an attached Hamamatsu C10600-10B camera and MetaMorph (version 7.7; MDS Analytical Technologies) software. Imaging of Figs 1a,b and 5g was performed with an inverted fluorescence microscope (TE2000-U, Nikon) equipped with an electron-multiplying CCD (charge-coupled device) camera (Cascade II, Photometrics) and a Yokogawa spinning-disc confocal system (CSU-Xm2, Nikon) and MetaMorph software. For quantification of immunoblotting, exposed films were scanned by an HP scanner and quantified by ImageJ software.
Statistical analysis. Unpaired one-way Student's t -test was performed and the P value was calculated for each experiment. Normality and homoscedasticity were justified using a graphical method and an F -test. For all experiments with error bars, the standard deviation (s.d.) was calculated to indicate the variation within each experiment. Five pairs (WT/KO) of animals or 5 independent experiments were chosen as the minimum number necessary to achieve statistically significant differences between groups at a difference in means of 40%. This calculation was made assuming a significance level of 0.05 and a power level of 0.90. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Figure S9 continued Uncropped images of immunoblots shown in Fig. 8a 
